A recent study using a murine lung cancer model reported that CD38 expression on cancer cells was upregulated in response to PD-1/PD-L1 blockade, resulting in the inhibition of CD8+ T-cell function via adenosine receptor signaling (19). This evidence concerns the gene CD38 and cancer.